Treatment of type Ii hyperlipoproteinaemia with cholestyramine
Schade, R.W.; Laar A van't; Jansen, A.P.
Netherlands Journal of Medicine 16(6): 254-259
1973
ISSN/ISBN: 0300-2977 PMID: 4767765 Document Number: 57547
Document emailed within 1 workday
Related Documents
Antonaci, S.; Jirillo, E.; Garofalo, A.R.; Polignano, A.; Resta, F.; Pugliese, P.; Capurso, A.; Bonomo, L. 1988: Cell-mediated immune response in patients with type IIa, type IIb and type IV primary hyperlipoproteinaemia Cytobios 54(218-219): 181-189Majewska, K.; Ciswicka-Sznajdermanowa, M.; Czechowicz-Janicka, K. 1977: Eye changes in hyperlipoproteinaemia type Ii Klinika Oczna 47(4): 175-177
Potter, J.M.; Macdonald, W.B. 1979: Primary type I hyperlipoproteinaemia--a metabolic and family study Australian and New Zealand Journal of Medicine 9(6): 688-693
Gariot, P.; Seurot, J.M.; Pointel, J.P.; Contet-Audonneau, J.L.; Gay, G.; Drouin, P.; Debry, G. 1982: The liver and primary type IV hyperlipoproteinaemia: a pathological study Human Nutrition. Clinical Nutrition 36(5): 351-361
Micheli, H.; Pometta, D.; Gustafson, A. 1980: Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins a and B in type IIa HLP La Nouvelle Presse Medicale 9(49): 3759-3762
Canetti, M.; Moreira, M.; Mas, R.; Illnait, J.; Fernandez, L.; Fernandez, J.; Diaz, E.; Castano, G. 1995: A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia International Journal of Clinical Pharmacology Research 15(4): 159-165
Sobra, J.; Heyrovský, A. 1972: Inborn errors of lipid metabolism. Familial hyperlipoproteinaemia type 3. Detection of heterozygotes Review of Czechoslovak Medicine 18(1): 34-39
Berger, G.M.; Van der Westhuyzen, J.H.; Huskisson, J.; Bonnici, F.; Henderson, H.E. 1982: Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotype South African Medical Journal 61(8): 266-272
Nye, E.R.; Sutherland, W.H.; Temple, W.a. 1980: The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate New Zealand Medical Journal 92(671): 345-349
Tashev, T.; Brailski, K.; Braikova, N.; Mendizova, A.; Adzharov, D. 1974: Treatment of cholestasis with cholestyramine Vutreshni Bolesti 13(1): 60-65
Acuña, R.; González Ceron, M. 1977: Hypoprothrombinemia and bleeding associated to treatment with cholestyramine Revista Medica de Chile 105(1): 27-28
Reddy, C.M.; Hara, S.; Crump, E.P. 1977: Cholestyramine treatment of intractable diarrhea Journal of the Tennessee Medical Association 70(9): 643; 61
Loginov, A.S.; Iartseva, A.M.; Kriukova, L.V. 1973: Cholestyramine treatment of patients with intrahepatic cholestasis Sovetskaia Meditsina 36(8): 90-94
Curtis, L.D.; Dickson, A.C.; Ling, K.L.; Betteridge, J. 1988: Combination treatment with cholestyramine and bezafibrate for heterozygous familial hypercholesterolaemia Bmj 297(6642): 173-175
Couture, P. 1972: Cholestyramine treatment of diarrhea caused by intestinal resection (choleretic enteropathy) Giornale di Clinica Medica 53(1): 10-14
Rateau, J.G.; Brouillard, M.; Morgant, G.; Aymard, P. 1986: Experimental study in the rabbit of the effect of cholestyramine in the treatment of infectious diarrhea caused by cholera Annales de Gastroenterologie et d'Hepatologie 22(5): 289-296
Hellström, K.; Einarsson, K. 1977: Bile acid metabolism in hyperlipoproteinaemia Clinics in Gastroenterology 6(1): 103-128
Lawrie, T.D.; Lorimer, A.R.; Ballantyne, D.; Jubb, J.S.; Morgan, H.G. 1975: The prevalence of hyperlipoproteinaemia in vascular disease Postgraduate Medical Journal 51(8): 7-15
Farid, N.R.; Dickinson, P.H.; MacNeal, I.F.; Anderson, J. 1974: Hyperlipoproteinaemia in peripheral arterial disease in the north of England Journal of Cardiovascular Surgery 15(3): 366-372
Ramaswami, P.K.; Senior, D.C. 1979: Klinefelter's syndrome with agenesis of kidney, diabetes, hyperlipoproteinaemia and stroke British Journal of Clinical Practice 33(5): 142-143